28-year late spermatic cord relapse of a testicular non-seminomatous germ cell tumour, managed robotically

  • James R. Hayes University of Toronto
  • Michael A.S. Jewett University of Toronto
  • Robert J. Hamilton University of Toronto

Abstract

We present a patient who relapsed symptomatically 28 years postorchiectomy, initially followed by active surveillance for clinical stage I non-seminomatous germ cell tumour (CSI NSGCT). His relapse was localized to the pelvis, managed with robotic surgery, and achieved a complete resection with tumour markers normalized. We highlight the current Princess Margaret guidelines for followup of CSI NSGCT and discuss the trade-off between lifelong radiographic surveillance to detect the very small risk of late relapse. We discuss the incidence and presentation of late relapse, treatment options, and outcomes, highlighting that these tumours are typically refractory to chemotherapy and can often be managed with surgery alone.

Author Biographies

James R. Hayes, University of Toronto

James Hayes

Medical Student (Class of 2018), University of Toronto

Dept. of Surgical Oncology (Urology), Princess Margaret Cancer Centre

Michael A.S. Jewett, University of Toronto

Dr. Michael Jewett

Staff Urologist

Dept. of Surgical Oncology (Urology), Princess Margaret Cancer Centre

Robert J. Hamilton, University of Toronto

Dr. Robert Hamilton

Staff Urologist

Dept. of Surgical Oncology (Urology), Princess Margaret Cancer Centre

Published
2016-07-12
How to Cite
Hayes, J., Jewett, M., & Hamilton, R. (2016). 28-year late spermatic cord relapse of a testicular non-seminomatous germ cell tumour, managed robotically. Canadian Urological Association Journal, 10(7-8), E257-60. https://doi.org/10.5489/cuaj.3492
Section
Residents' Room